Can’t Finish Your To-Do Lists? Try These StrategiesThe day often starts with a fresh to-do list and a lot of good intentions. After a few interruptions and diversions, the hours pass too…Jan 5, 2021Jan 5, 2021
Stamina: How Leaders Stay Energized Through It AllWhen seas are calm, the captain of the ship is largely unnecessary. It’s only when the winds pick up, the seas get rough, or the ship…Jan 5, 2021Jan 5, 2021
Bilogix Provides Enterprise Performance Management SolutionsAn experienced executive in the pharmaceutical industry, John Klein serves as the chairman of Cambridge Therapeutics in Alpine, NJ. In…Dec 10, 2020Dec 10, 2020
Bilogix — Enterprise Performance Management Consulting FocusJohn Klein is an established presence in the Alpine, New Jersey, entrepreneurial community who leads Cambridge Therapeutics and provides…Dec 10, 2020Dec 10, 2020
Bilogix Provides Clients Enterprise Performance Management SolutionsA longtime Alpine, New Jersey, entrepreneur, John Klein is the chairman of Cambridge Therapeutics, where he leads a company that…Dec 10, 2020Dec 10, 2020
Burnt Out? Do Something About ItThere is no doubt that today’s “hustle culture” has bred some of the most successful and ambitious entrepreneurs. But while you and the…Nov 24, 2020Nov 24, 2020
Why You Should Get to Know Your CompetitionThere is no better way to get ahead in your industry than to learn about your competition. You are in the same industry and are likely…Nov 24, 2020Nov 24, 2020
The Difference Between Leading and Lagging Key Performance IndicatorsAn Alpine, NJ-based pharmaceutical executive, John Klein has served as chairman of Cambridge Therapeutics since 2011. John Klein…Nov 18, 2020Nov 18, 2020
Enterprise Performance Management — A Pathway to Optimized OperationsGuiding Cambridge Therapeutics, John Klein is an established presence in the Alpine, New Jersey entrepreneurial community who has set in…Nov 16, 2020Nov 16, 2020
Repositioning Businesses through Enterprise Performance ManagementA business leader in Alpine, NJ, John Klein serves as the chairman and CEO of Cambridge Therapeutics, where he emphasizes a…Nov 16, 2020Nov 16, 2020